Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injury.
Mikus M, Drobin K, Gry M, Bachmann J, Lindberg J, Yimer G, Aklillu E, Makonnen E, Aderaye G, Roach J, Fier I, Kampf C, Göpfert J, Perazzo H, Poynard T, Stephens C, Andrade RJ, Lucena MI, Arber N, Uhlén M, Watkins PB, Schwenk JM, Nilsson P, Schuppe-Koistinen I. Mikus M, et al. Among authors: perazzo h. Liver Int. 2017 Jan;37(1):132-140. doi: 10.1111/liv.13174. Epub 2016 Jun 22. Liver Int. 2017. PMID: 27224670 Free PMC article.
Serum apolipoprotein A1 and haptoglobin, in patients with suspected drug-induced liver injury (DILI) as biomarkers of recovery.
Peta V, Tse C, Perazzo H, Munteanu M, Ngo Y, Ngo A, Ramanujam N, Verglas L, Mallet M, Ratziu V, Thabut D, Rudler M, Thibault V, Schuppe-Koistinen I, Bonnefont-Rousselot D, Hainque B, Imbert-Bismut F, Merz M, Kullak-Ublick G, Andrade R, van Boemmel F, Schott E, Poynard T; Drug Induced Liver Injury- Groupe Hospitalier Pitié-Salpêtrière; Drug Induced Liver Group of the Injury Safer and Faster Evidence-based Translation consortium. Peta V, et al. Among authors: perazzo h. PLoS One. 2017 Dec 29;12(12):e0189436. doi: 10.1371/journal.pone.0189436. eCollection 2017. PLoS One. 2017. PMID: 29287080 Free PMC article.
What are the best reference values for a normal serum alanine transaminase activity (ALT)? Impact on the presumed prevalence of drug induced liver injury (DILI).
M'Kada H, Munteanu M, Perazzo H, Ngo Y, Ramanujam N, Imbert-Bismut F, Ratziu V, Bonnefont-Rousselot D, Souberbielle B, Schuppe-Koistinen I, Poynard T; DILI group of the SAFE-T consortium. M'Kada H, et al. Among authors: perazzo h. Regul Toxicol Pharmacol. 2011 Aug;60(3):290-5. doi: 10.1016/j.yrtph.2011.04.002. Epub 2011 Apr 24. Regul Toxicol Pharmacol. 2011. PMID: 21539883
Real time identification of drug-induced liver injury (DILI) through daily screening of ALT results: a prospective pilot cohort study.
M'Kada H, Perazzo H, Munteanu M, Ngo Y, Ramanujam N, Fautrel B, Imbert-Bismut F, Ratziu V, Schuppe-Koistinen I, Leblond V, Delattre JY, Samson Y, Caen OL, Bricaire F, Khayat D, Pierrot-Deseilligny C, Herson S, Amoura Z, Tilleul P, Deckmyn O, Coriat P, Delpech VN, Boulogne P, Bonnefont-Rousselot D, Poynard T; Drug Induced Liver Injury Groupe Hospitalier Pitié-Salpêtrière Group; Safer and Faster Evidence-based Translation Consortium. M'Kada H, et al. Among authors: perazzo h. PLoS One. 2012;7(8):e42418. doi: 10.1371/journal.pone.0042418. Epub 2012 Aug 14. PLoS One. 2012. PMID: 22905129 Free PMC article.
The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis.
Poynard T, Peta V, Munteanu M, Charlotte F, Ngo Y, Ngo A, Perazzo H, Deckmyn O, Pais R, Mathurin P, Myers R, Loomba R, Ratziu V; FLIP consortium, the FibroFrance-CPAM group, the FibroFrance-Obese group, and the Selonsertib group. Poynard T, et al. Among authors: perazzo h. Eur J Gastroenterol Hepatol. 2019 Mar;31(3):393-402. doi: 10.1097/MEG.0000000000001304. Eur J Gastroenterol Hepatol. 2019. PMID: 30516570 Free PMC article.
Diagnostic performance of a new noninvasive test for nonalcoholic steatohepatitis using a simplified histological reference.
Poynard T, Munteanu M, Charlotte F, Perazzo H, Ngo Y, Deckmyn O, Pais R, Merrouche W, de Ledinghen V, Mathurin P, Ratziu V; FLIP Consortium, the FibroFrance-CPAM Group, the FibroFrance-Obese Group. Poynard T, et al. Among authors: perazzo h. Eur J Gastroenterol Hepatol. 2018 May;30(5):569-577. doi: 10.1097/MEG.0000000000001064. Eur J Gastroenterol Hepatol. 2018. PMID: 29406435
Impact of steatosis and inflammation definitions on the performance of NASH tests.
Poynard T, Munteanu M, Charlotte F, Perazzo H, Ngo Y, Deckmyn O, Pais R, Mathurin P, Ratziu V; FLIP consortium, the FibroFrance-CPAM group; FibroFrance-Obese group. Poynard T, et al. Among authors: perazzo h. Eur J Gastroenterol Hepatol. 2018 Apr;30(4):384-391. doi: 10.1097/MEG.0000000000001033. Eur J Gastroenterol Hepatol. 2018. PMID: 29280921 Free PMC article.
Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemia.
Perazzo H, Munteanu M, Ngo Y, Lebray P, Seurat N, Rutka F, Couteau M, Jacqueminet S, Giral P, Monneret D, Imbert-Bismut F, Ratziu V, Hartemann-Huertier A, Housset C, Poynard T; FLIP Consortium. Perazzo H, et al. Aliment Pharmacol Ther. 2014 Nov;40(9):1081-93. doi: 10.1111/apt.12946. Epub 2014 Sep 3. Aliment Pharmacol Ther. 2014. PMID: 25186086 Free article.
76 results